Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma
- PMID: 30145314
- PMCID: PMC6589432
- DOI: 10.1016/j.gie.2018.08.029
Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma
Abstract
Background and aims: Pancreatic intraepithelial neoplasia is associated with chronic pancreatitis (CP) changes on EUS. The objective of this study was to determine whether CP changes were more common in high-risk individuals (HRIs) than in control subjects and whether these changes differed among higher-risk subsets of HRIs.
Methods: HRIs and control subjects were identified from an endoscopy database. HRIs were defined as having predisposing mutations or a family history (FH) of pancreatic ductal adenocarcinoma. HRIs were classified as vHRIs who met Cancer of the Pancreas Screening (CAPS) criteria for high risk and mHRIs who did not. Multivariable logistic regression was used to adjust for confounders and CP risk factors.
Results: Sixty-five HRIs (44 vHRIs, 21 mHRIs) and 118 control subjects were included. HRIs were included for FH (25), Lynch syndrome (5), Peutz-Jeghers syndrome (2), and mutations in BRCA1/2 (26), PALB2 (3), ATM (3), and CDKN2A (1). After adjustment for relevant variables, HRIs were 16 times more likely to exhibit 3 or more CP changes than control subjects (95% confidence interval, 2.6-97.0; P = .003). HRIs were also more likely to have hypoechoic foci (odds ratio, 8.0; 95% confidence interval, 1.9-32.9; P = .004). vHRIs and mHRIs did not differ in frequency of 3 or more CP changes on EUS.
Conclusions: HRIs were more likely to exhibit CP changes and hypoechoic foci on EUS compared with control subjects. HRIs with these findings may require closer surveillance. HRIs who did or did not meet CAPS criteria did not differ with regard to CP findings, supporting a more inclusive approach to screening.
Copyright © 2019 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Chronic pancreatitis-like changes in individuals at high risk for the development of pancreatic cancer: What is the significance?Gastrointest Endosc. 2019 Apr;89(4):852-854. doi: 10.1016/j.gie.2019.01.023. Gastrointest Endosc. 2019. PMID: 30902206 No abstract available.
References
-
- Anon. Pancreatic cancer—cancer stat facts. Available at: https://seer.cancer.gov/statfacts/html/pancreas.html. Accessed February 15, 2018.
-
- Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC pancreatic cancer staging system. Cancer 2007;110:738–44. - PubMed
-
- Bartsch DK, Slater EP, Carrato A, et al. Refinement of screening for familial pancreatic cancer. Gut 2016;65:1314–21. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
